Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE u-turn on Opdivo for skin cancer recurrence

pharmatimesNovember 30, 2018

Tag: Opdivo , nivolumab , melanoma

PharmaSources Customer Service